Ensayos colaborativos adaptativos de Melanoma Internacional: Informe de progreso
El primer ensayo de plataforma adaptativa en melanoma -y uno de los únicos ensayos de plataforma adaptativa que existirá durante...
11/13/2018
Ensayos colaborativos adaptativos de Melanoma Internacional: Informe de progreso
El primer ensayo de plataforma adaptativa en melanoma -y uno de los únicos ensayos de plataforma adaptativa que existirá durante...
|
|
11/13/2018
The Melanoma Tissue Bank: Progress Report
As we look back through 2018, perhaps the most exciting news from AIM at Melanoma is the progress on what…
|
|
09/04/2018
Preguntas y respuestas de tres destacados especialistas en melanoma
Eric D. Whitman, MD Medical Director, Atlantic Health System Cancer Care Director, Atlantic Melanoma Center Question: Which clinical trials do…
|
04/27/2018
Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute
Dr. Omid Hamid is recognized nationally and internationally as a key opinion leader in Immuno-Oncologic Drug Development and Melanoma…
|
Entradas recientes
May. 01, 2024
May is Melanoma Awareneness Month
Apr. 16, 2024
Navigating the Journey Together – Conversations with Melanoma Caregivers
Apr. 12, 2024
May is Brain Tumor Awareness Month
Apr. 11, 2024
President’s Letter | April 2024
Apr. 11, 2024